Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals IncfiledCriticalSciclone Pharmaceuticals Inc
Publication of MY110041ApublicationCriticalpatent/MY110041A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
COMPOSITIONS AND METHODS OF USE FOR TREATING HEPATITIS C VIRUS-INFECTED MAMMALS ARE DISCLOSED. THE COMPOSITIONS INCLUDE ONE OR MORE THYMOSINS ALONE OR IN COMBINATION WITH ONE OR MORE INTERFERONS. METHODS OF TREATMENT INCLUDE USE OF THYMOSINS ALONE, OR TOGETHER, OR SEQUENTIALLY WITH INTERFERON.
MYPI92001633A1991-09-131992-09-12Composition and method of treating hepatitis c
MY110041A
(en)